Bullous pemphigoid: the frequency of mucosal involvement and concurrent malignancy related to indirect immunofluorescence findings

The British Journal of Dermatology
L HodgeM F Corbett

Abstract

A review of 124 cases of bullous pemphigoid was made and the clinical findings correlated with the results of indirect immunofluorescence. A circulating IgG basement membrane zone (BMZ) antibody was detected in the serum of eighty-nine (72%) of the patients. Antibody titres in these patients did not correlate with the extent of the disease or with the presence of mucous membrane lesions. Indeed, oral lesions were more common in the thirty-five sero-negative patients with 17% of such patients being affected compared to only 10% of those with positive indirect immunofluorescence findings. This difference, however, was not statistically significant. Concurrent malignant disease (i.e. malignancy occurring within 6 months of pemphigoid being diagnosed) occurred in eight of the seronegative group (23%) and in only four of the eighty-nine seropositive cases (4%); this difference was significant. The association of bullous pemphigoid and malignant disease still remains controversial, but those who believe that the relationship is coincidental must now explain why concurrent malignant disease is more common in patients who have bullous pemphigoid and negative indirect immunofluorescence findings.

References

Jun 1, 1978·Archives of Dermatology·M V Dahl, S Ristow
Aug 1, 1977·Archives of Dermatology·A R AhmedT T Provost
Nov 1, 1979·The British Journal of Dermatology·J A Savin
Dec 1, 1968·British Journal of Cancer·R L Parsons, J A Savin
Feb 1, 1953·Medicine·W F LEVER
Dec 1, 1953·The British Journal of Dermatology·E WADDINGTON
Dec 3, 1955·British Medical Journal·I B SNEDDON, R CHURCH

❮ Previous
Next ❯

Citations

Oct 1, 1993·Irish Journal of Medical Science·S EustaceD O'Connell
Mar 1, 1995·Journal of Dermatological Science·H OgawaY Inaba
Dec 4, 2001·Journal of the European Academy of Dermatology and Venereology : JEADV·E CozzaniUNKNOWN Gruppo Ligure di Studi in Dermatologia (GLISID)
Jan 13, 2000·International Journal of Dermatology·K P KyriakisA D Tosca
Jun 23, 2000·Annals of Periodontology·P Holmstrup
Jan 9, 2007·European Archives of Oto-rhino-laryngology : Official Journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : Affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery·Alfio FerlitoAlessandra Rinaldo
Mar 19, 2015·International Journal of Dermatology·Mahnaz BanihashemiHamed S Razavi
Jan 1, 1987·Clinics in Dermatology·M V Dahl
Jul 1, 1986·Clinical and Experimental Dermatology·P D MauriceW G Reeves
Jul 1, 1983·Clinical and Experimental Dermatology·M M BlackB Bhogal
Jan 29, 2000·The Annals of Otology, Rhinology, and Laryngology·A Ferlito, A Rinaldo
Aug 31, 2007·The Annals of Otology, Rhinology, and Laryngology·Alfio Ferlito, Alessandra Rinaldo
Feb 28, 2002·Clinical Pediatrics·Michael J NowickiPaul H Parker
Dec 22, 1999·Clinical and Experimental Dermatology·E GilmourC E Griffiths
Sep 1, 1987·The British Journal of Dermatology·R A Graham-Brown
Jun 1, 1988·The British Journal of Dermatology·A KazakisR Anderson
Jan 1, 1986·International Journal of Dermatology·H N LiuR S Rogers
May 17, 2005·Drugs·Scott R A WalshP Régine Mydlarski
Dec 6, 2019·Advances in Therapy·Alessandra RinaldoAlfio Ferlito
Oct 1, 1990·The British Journal of Dermatology·V A Venning, F Wojnarowska
Apr 1, 1994·The Journal of Dermatology·T YamamotoY Furuse
Feb 1, 1993·Journal of the American Academy of Dermatology·S Poole, N A Fenske

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.